SOX2 and cancer: Real-time PCR of MDA-MB-231 with increasing concentrations of a small molecular cancer stemness inhibitor, BBI-608, demonstrated stepwise decreases in expressions of Nanog, Sox2, and Oct4 stemness markers (shown in supplemental data).